Investing in innovation

Written by   in 

Dear Colleagues, 

As the facilitator of technology transfer at Clemson University, our goal is to help Clemson faculty, staff, and students move their innovative technologies out of the classroom and into the market. With the year swiftly coming to a close, and a new year upon us, I want to remind you of all the resources we have available to assist you in accelerating the commercialization of your technology.  

In an effort to advance your research, we offer two unique funding opportunities designed to support the development and implementation of new technologies. 

Our Technology Maturation Fund, unlike any other source of funding available to Clemson faculty, offers researchers additional support as they embark on the crucial last stage needed to move their technologies from innovation to commercialization. Since its inception in 2014, more than $870,000 in maturation funds have been awarded to Clemson researchers. 

In addition to the Technology Maturation Fund, we have recently instituted a new funding program that provides healthcare-focused grants to researchers. The new Innovation Maturation Fund program is intended to foster growth and market implementation of novel health science innovations.

As always, we are here to support your innovations by protecting, maturing, and marketing your technologies, and are committed to investing in you and your research. I hope you will find these resources useful as you continue to advance your research portfolio. 

If you need assistance with any aspect of your research journey, please fill out this form and we will get back to you as soon as possible.  

Have a safe and happy holiday season! 

Best, 

Chris

Networking hub to promote collaboration and accelerate commercialization of technologies 

Written by   in 

The Southeast XLerator Network is a Regional Technology Transfer Accelerator Hub that will promote collaboration and participation among faculty, students, and researchers by developing a number of online resources that educate researchers on how to effectively write SBIR/STTR grant submissions and commercialize their technologies. 

Using an invaluable network of educational resources, mentors, and expertise, the hub aims to increase SBIR funding and increase the commercialization of healthcare and biomedical technologies in the typically underserved Southeast IDeA state region.

XLerateHealth, a company that has worked with more than two-hundred early-stage healthcare startups, is the SBC recipient of the award for the XLerator Hub, one of four IDeA State Regions to receive a National Institute of Health STTR grant, with the University of Kentucky as the STTR academic partner institution.

The Southeast IDeA States region includes six states (KY, WV, SC, AR, MS, LA) plus Puerto Rico, each of which has a designated state lead institution comprised of representative leads, and 24 partnering academic institutions. State leads, which are part of the Internal Advisory Committee (IAC), coordinate communications and operations in conjunction with the other 16 academic partner institutions. These participating institutions, including Clemson University and the Medical University of South Carolina, each have an appointed site lead who facilitate engagement by building a number of online resources that give faculty, students, and researchers the opportunity to learn about ways to successfully commercialize their technologies. 

The Southeast XLerator Network leverages and connects existing assets to bridge the gap between innovative ideas and commercialization, in an effort to promote a long-lasting, entrepreneurial culture among researchers at research institutions.

To learn more about the XLerator Network, click here

Inventor Spotlight: Daniel Whitehead

Written by   in 

Dr. Daniel Whitehead, an associate professor in the department of chemistry at Clemson University, is revolutionizing chemistry with his research in new reaction methodology, materials chemistry, and bio-organic chemistry. Prior to joining Clemson in 2011, Dr. Whitehead received both his bachelor’s and master’s degree from Furman University. Whitehead received his Ph.D. from Michigan State University in 2009, where he focused his doctoral studies on the development of an asymmetric chlorolactonization protocol under the mentorship of Professor Babak Borhan. During his time as a postdoctoral fellow at North Carolina State University from 2009 to 2011, Whitehead researched and developed novel therapeutics including anti-biofilm agents, osteoclastogenesis inhibitors, and nanoparticle-drug conjugates for the treatment of HIV infections.

Whitehead is currently working to leverage synthetic organic chemistry through the exploration of a variety of research projects, including a National Science Foundation-funded project focused on the development of enantioselective hypervalent iodine catalysts. In collaboration with other Clemson researchers, Whitehead has also developed a series of biodegradable, functional nanoparticles that are capable of capturing VOC pollutants associated with industrial waste streams.  Along with their many other innovative contributions, the Whitehead group was recently awarded a Technology Maturation Fund grant from the Clemson University Research Foundation for their ongoing work with the Clemson University Eukaryotic Pathogens Innovation Center (EPIC). This collaborative project with Professor Jim Morris in CU Biochemistry and Genetics, focuses on validating a new class of compounds, the diazacyclobutenes, as potential therapeutics for the treatment of infections of eukaryotic pathogens such as Trypanosoma brucei, the causative agent of African Sleeping Sickness. 

In addition to his academic achievements, Dr. Whitehead is passionate about scientific outreach, co-founding a program in 2009 to facilitate laboratory exercises for area homeschool students. He frequently collaborates with an area Montessori pre-primary and primary school to conduct hands-on science experiments, demonstrations, and a week-long science summer camp.

To learn more about Dr. Whitehead, click here.